Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Analysis of Incidence and Mortality of Thyroid Cancer in China, 2013].
Yang L, Zheng RS, Wang N, Zeng HM, Yuan YN, Zhang SW, Li HC, Liu S, Chen WQ, He J. Yang L, et al. Among authors: yuan yn. Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):862-867. doi: 10.3760/cma.j.issn.0253-3766.2017.11.010. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29151294 Chinese.
[Analysis on the consciousness of the early cancer treatment and its influencing factors among urban residents in China from 2015 to 2017].
Li HC, Wang K, Yuan YN, Mao AY, Liu CC, Liu S, Yang L, Huang HY, Dong P, Wang DB, Liu GX, Liao XZ, Bai YN, Sun XJ, Ren JS, Yang L, Wei DH, Song BB, Lei HK, Liu YQ, Zhang YZ, Ren SY, Zhou JY, Wang JL, Gong JY, Yu LZ, Liu YY, Zhu L, Guo LW, Wang YQ, He YT, Lou PA, Cai B, Sun XH, Wu SL, Qi X, Zhang K, Li N, Dai M, Chen WQ, Wang N, Qiu WQ, Shi JF. Li HC, et al. Among authors: yuan yn. Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jan 6;54(1):69-75. doi: 10.3760/cma.j.issn.0253-9624.2020.01.014. Zhonghua Yu Fang Yi Xue Za Zhi. 2020. PMID: 31914572 Chinese.
[Efficacy analysis of chemotherapy and endocrine therapy combined with targeted drugs after progression on cyclin-dependent kinase 4/6 inhibitor treatment in hormone receptor positive/human epidermal growth factor receptor 2-low metastatic breast cancer].
Liu B, Yuan Y, Li F, Li JB, Bian L, Wang T, Zhang SH, Jiang ZF. Liu B, et al. Zhonghua Yi Xue Za Zhi. 2024 May 7;104(17):1507-1513. doi: 10.3760/cma.j.cn112137-20240207-00296. Zhonghua Yi Xue Za Zhi. 2024. PMID: 38706058 Chinese.
[Response characteristics of tislelizumab combined with chemotherapy in first-line treatment of locally advanced or metastatic non-squamous non-small cell lung cancer].
Lu S, Yu XM, Hu YP, Ma ZY, Li XY, Li WD, Liu YP, Wang D, Wang XW, Wang ZH, Wu JX, Zhong DS, Li GF, He WY, Bao YY, Yuan Y, Fan JH. Lu S, et al. Zhonghua Zhong Liu Za Zhi. 2023 Apr 23;45(4):358-367. doi: 10.3760/cma.j.cn112152-20220928-00662. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 37078218 Clinical Trial. Chinese.
32 results